BR112015003101A2 - processo para a preparação de um composto. - Google Patents

processo para a preparação de um composto.

Info

Publication number
BR112015003101A2
BR112015003101A2 BR112015003101A BR112015003101A BR112015003101A2 BR 112015003101 A2 BR112015003101 A2 BR 112015003101A2 BR 112015003101 A BR112015003101 A BR 112015003101A BR 112015003101 A BR112015003101 A BR 112015003101A BR 112015003101 A2 BR112015003101 A2 BR 112015003101A2
Authority
BR
Brazil
Prior art keywords
compound
preparation
Prior art date
Application number
BR112015003101A
Other languages
English (en)
Other versions
BR112015003101B1 (pt
Inventor
Hossner Frank
Bryce Strachan John
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BR112015003101A2 publication Critical patent/BR112015003101A2/pt
Publication of BR112015003101B1 publication Critical patent/BR112015003101B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
BR112015003101-3A 2012-08-15 2013-08-14 Processo para a preparação de um composto BR112015003101B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261683369P 2012-08-15 2012-08-15
US61/683,369 2012-08-15
PCT/EP2013/067035 WO2014027045A1 (en) 2012-08-15 2013-08-14 Chemical process

Publications (2)

Publication Number Publication Date
BR112015003101A2 true BR112015003101A2 (pt) 2017-07-04
BR112015003101B1 BR112015003101B1 (pt) 2022-06-14

Family

ID=49080842

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015003101-3A BR112015003101B1 (pt) 2012-08-15 2013-08-14 Processo para a preparação de um composto

Country Status (12)

Country Link
US (2) US9273001B2 (pt)
EP (2) EP3401316B1 (pt)
JP (2) JP6389174B2 (pt)
KR (1) KR20150043465A (pt)
CN (2) CN104619706B (pt)
AU (3) AU2013304102B2 (pt)
BR (1) BR112015003101B1 (pt)
CA (1) CA2881935A1 (pt)
ES (2) ES2893473T3 (pt)
IN (1) IN2015KN00323A (pt)
RU (1) RU2644160C2 (pt)
WO (1) WO2014027045A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2959699T3 (es) 2014-05-28 2024-02-27 Glaxosmithkline Ip Dev Ltd Furoato de fluticasona en el tratamiento de la EPOC
US10023535B2 (en) 2014-11-03 2018-07-17 Olon S.P.A. Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters
PT108370B (pt) 2015-03-30 2018-10-25 Hovione Farm S A Processo de preparação de brometo de aclidínio
EP3248970A1 (en) 2016-05-27 2017-11-29 Zentiva K.S. Forms of umeclidinium bromide
PT109740B (pt) * 2016-11-14 2020-07-30 Hovione Farmaciencia Sa Processo para a preparação de brometo de umeclidínio
CN108069956B (zh) * 2016-11-18 2021-03-16 扬州奥锐特药业有限公司 1-氮杂双环[2,2,2]辛-4-基苯基酮化合物及其制备方法和应用
IT201700058796A1 (it) * 2017-05-30 2018-11-30 Olon Spa Procedimento per la preparazione di un nuovo intermedio di sintesi dell’umeclidinio.
CN107935917A (zh) * 2017-10-30 2018-04-20 广东莱佛士制药技术有限公司 一种1‑(2‑氯乙基)‑4‑哌啶甲酸酯的合成方法
CN109956938A (zh) * 2017-12-26 2019-07-02 天津金耀集团有限公司 乌美溴铵中间体晶型及其制备方法和以该中间体制备乌美溴铵的方法
CN108558860B (zh) * 2018-06-04 2020-12-25 成都伊诺达博医药科技有限公司 一种合成芜地溴铵的方法
PT115583B (pt) 2019-06-17 2022-05-02 Hovione Farm S A Processo contínuo para a preparação de medicamentos anticolinérgicos
PT117440A (pt) 2021-09-03 2023-03-03 Hovione Farm S A Processo para a preparação de aminas cíclicas cloroaquilo substituídas
CN117310022A (zh) * 2023-09-22 2023-12-29 山东泰合医药科技有限公司 一种分离和检测乌美溴铵中间体奎宁环二苯甲醇有关物质的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998832A (en) * 1975-04-16 1976-12-21 G. D. Searle & Co. Anti-diarrheal compounds
US4540780A (en) * 1983-06-02 1985-09-10 Warner-Lambert Company Diphenylmethylene piperidines
FR2816618B1 (fr) * 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
AR050902A1 (es) * 2004-04-27 2006-12-06 Glaxo Group Ltd Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
GB0519879D0 (en) * 2005-09-30 2005-11-09 Astrazeneca Ab Chemical process
JP4841279B2 (ja) * 2006-03-23 2011-12-21 一般財団法人 化学物質評価研究機構 被検物質の発がん性予測方法
WO2011029896A1 (en) * 2009-09-11 2011-03-17 Glaxo Group Limited Methods of preparation of muscarinic acetylcholine receptor antagonists
KR101886467B1 (ko) * 2011-01-31 2018-08-07 비브 헬스케어 유케이 (넘버4) 리미티드 Hiv 성숙 억제 활성을 갖는 c-17 및 c-3 변형 트리테르페노이드

Also Published As

Publication number Publication date
CA2881935A1 (en) 2014-02-20
WO2014027045A1 (en) 2014-02-20
ES2678697T3 (es) 2018-08-16
RU2644160C2 (ru) 2018-02-08
AU2013304102A1 (en) 2015-02-26
CN107163038A (zh) 2017-09-15
AU2013304102B2 (en) 2016-09-01
AU2016213768B2 (en) 2018-01-04
BR112015003101B1 (pt) 2022-06-14
IN2015KN00323A (pt) 2015-07-10
AU2016213768A1 (en) 2016-09-01
JP2018203752A (ja) 2018-12-27
JP6799037B2 (ja) 2020-12-09
RU2015104269A (ru) 2016-10-10
CN104619706A (zh) 2015-05-13
US20150232423A1 (en) 2015-08-20
US9273001B2 (en) 2016-03-01
JP2015524832A (ja) 2015-08-27
US20160159786A1 (en) 2016-06-09
CN107163038B (zh) 2020-07-28
EP2885298B1 (en) 2018-06-13
EP3401316A1 (en) 2018-11-14
ES2893473T3 (es) 2022-02-09
JP6389174B2 (ja) 2018-09-12
EP3401316B1 (en) 2021-08-04
US9657011B2 (en) 2017-05-23
AU2016262787A1 (en) 2016-12-15
KR20150043465A (ko) 2015-04-22
EP2885298A1 (en) 2015-06-24
CN104619706B (zh) 2017-06-20

Similar Documents

Publication Publication Date Title
BR112015003101A2 (pt) processo para a preparação de um composto.
BR112014026802A2 (pt) processo para a preparação de um a, \omega-cn diol.
BR112014008196A2 (pt) processo para a preparação de um composto
BR112014012414A8 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BR112014030071A2 (pt) processo para a fabricação de um vapor de dafd, e, composição
BR112015023670A2 (pt) processo para preparar um composto
BR112014015994A2 (pt) processo.
BR112016013492A2 (pt) processo para a preparação de ácidos alcanossulfônicos.
BR112013018945A2 (pt) processo para a preparação de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos.
BR112014004622A2 (pt) processo para a preparação de isocianatos
BR112014012243A2 (pt) processo de preparação de compostos
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BR112015021297A2 (pt) um processo para a produção de adenovírus.
BR112014028570A2 (pt) processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.
BR112014010997A2 (pt) processo para o preparo de ß-glicosídeos de c-arila
BR112014001769A2 (pt) processo para a preparação de 1,4-ciclo-hexanodimetanol
BR112013018942A2 (pt) processo para o preparo de 4-amino-3-cloro-5-fluro-6(substituído) picolinatos.
BR112014028589A2 (pt) processo para fabricação de compostos de ciclopentilpirimidina hidroxilada
BR112016010223A2 (pt) processo para a preparação de iopamidol.
BR112014003336A2 (pt) processo para a preparação de complexos de 68ga
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis
BR112014028585A2 (pt) processo para fabricação de compostos de aminoácido.
BR112014014052A2 (pt) processo para a preparação de 5-hidroximetilfurfural
BR112014010327A2 (pt) processo para a preparação de compostos
BR112012021379A2 (pt) processo para a preparação de um alqueno

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 453/02

Ipc: C07D 453/02 (2006.01), C07D 211/62 (2006.01), A61P

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/08/2013, OBSERVADAS AS CONDICOES LEGAIS